Data Foundry

Drug recalls 2026

Tirzepatide Injection — Class II drug recall D-0036-2027

Ongoing recall by Apothecary Pharma LLC, reported 2026-10-14, distributed nationwide. Lack of Assurance of Sterility

Recall numberD-0036-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmApothecary Pharma LLC, Cary, NC, United States
Recall initiated2026-09-24
Classified2026-10-08
Reported by FDA2026-10-14
DistributedNationwide (US)
Quantity22 vials
Reason classessterility
NDC85091-0001-18
Lot numbersAP-202622, AP-202623, AP-202624, AP-202625, AP-202627, AP-202628, AP-202629, AP-202630, AP-202631, AP-202632, AP-202633, AP-202634, AP-202635, AP-202636, AP-202637, AP-202638, AP-202639, AP-202640, AP-202641, AP-202642, AP-202643, AP-202644
Expiration dates2026-10-07, 2026-10-08, 2026-10-19, 2026-10-20, 2026-10-26, 2026-10-27, 2026-10-28, 2026-10-31, 2026-11-01, 2026-11-03, 2026-11-07, 2026-11-08, 2026-11-16, 2026-11-17, 2026-11-18, 2026-11-19, 2026-11-20, 2026-11-21, 2026-11-22, 2026-11-24, 2026-11-25, 2026-11-26

Product

Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.

Reason for recall

Lack of Assurance of Sterility

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0036-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-21. Not affiliated with or endorsed by FDA. Not medical or legal advice.